Castlight Health is to raise $176 million in IPO financing.
Castlight Health announced the pricing of its initial public offering of 11,100,000 shares of its Class B common stock at a price to the public of $16.00 per share.
Castlight Health has granted the underwriters a 30-day option to purchase up to 1,665,000 additional shares of Class B common stock from Castlight Health at the initial public offering price.
The shares are expected to begin trading on the New York Stock Exchange on March 14, 2014 under the symbol “CSLT.”
For further financing deal information visit Current Agreements (subscription required)
Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary
View: Current Partnering’s Financing Scorecard – view top life science financing deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity